Kenichiro Ikeda

Kenichiro Ikeda

Auto-generated profile, based on publicly available information

Kenichiro Ikeda

Department of Urology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2020 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
Yoshitaka HashimotoYoshitaka Hashimoto
Yoshitaka Hashimoto
RSRyosuke Sakai
Ryosuke Sakai
KIKenichiro Ikeda
Kenichiro Ikeda
Michiaki FukuiMichiaki Fukui
Michiaki Fukui
Background: We investigated the association between sleep symptoms, which cause sleep disorder, and quality of life (QoL) among people with type 2 diabetes (T2D). Methods: In this cross-sectional study of 342 people with T2D, the Japan National Health and Wellness Survey (NHWS) database 2016 were used. We treated the respondents who reported experiencing any of the sleep symptoms as having sleep disorders. To examine health-related QoL (HRQoL), we used the physical component summary (PCS) and the mental component summary (MCS) from the 36-Item short-form and the EuroQol 5 Dimension (EQ-5D) survey instruments. Overall activity impairment was used for assessment of the effect on the individual’s ability to perform regular daily activities. We used t-test and one-way ANOVA test for comparison QoL scores between the participants with and without sleep disorders. Results: 66.4% of the participants with T2D reported having a sleep disorder. The PCS, MCS, EQ-5D, and overall activity impairment of people with sleep disorder was significantly poorer than those of the people without. Specific sleep symptoms, such as waking up to go to the bathroom, daytime sleepiness, and waking up too early (before the alarm clock), had high prevalence (35.4, 27.8 and 20.2%). The participants who experienced waking up to go to the bathroom or daytime sleepiness demonstrated significantly poorer QoL on all scores related to QoL, but those who experienced waking up too early only demonstrated significantly poorer QoL on the EQ-5D. Conclusions: Two-thirds of people with T2D in this study suffer from sleep disorders. The people who experience waking up to go to the bathroom or daytime sleepiness had significantly poorer QoL than those without these symptoms. Thus, sleep disorders, especially the symptoms of waking up to go to the bathroom or daytime sleepiness, might be the treatment targets for QOL of people with T2DM.

21 October 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Sekino YoheiSekino Yohei
Sekino Yohei
QPQuoc Thang Pham
Quoc Thang Pham
KKKohei Kobatake
Kohei Kobatake
HKHiroyuki Kitano
Hiroyuki Kitano
KIKenichiro Ikeda
Kenichiro Ikeda
NHNobuyki Hinata
Nobuyki Hinata
Kinesin family member C1 (KIFC1), a minus end-directed motor protein, is reported to play an essential role in cancer. This study aimed to analyze KIFC1 expression and examine KIFC1 involvement in cisplatin resistance in bladder cancer (BC). Immunohistochemistry showed that 37 of 78 (47.4%) BC cases were positive for KIFC1. KIFC1-positive cases were associated with high T stage and lymph node metastasis. Kaplan-Meier analysis showed that KIFC1-positive cases were associated with poor prognosis, consistent with the results from public databases. Molecular classification in several public databases indicated that KIFC1 expression was increased in basal type BC. Immunohistochemistry showed that KIFC1-positive cases were associated with basal markers 34βE12, CK5 and CD44. KIFC1 expression was increased in altered TP53 compared to that in wild-type TP53. Immunohistochemistry showed that KIFC1-positive cases were associated with p53-positive cases. P53 knockout by CRISPR-Cas9 induced KIFC1 expression in BC cell lines. Knockdown of KIFC1 by siRNA increased the sensitivity to cisplatin in BC cells. Kaplan-Meier analysis indicated that prognosis was poor among KIFC1-positive BC patients treated with cisplatin-based chemotherapy. Immunohistochemistry showed that KIFC1-positive cases were associated with PD-L1-positive cases. High KIFC1 expression was associated with a favorable prognosis in patients treated with atezolizumab from the IMvigor 210 study. These results suggest that KIFC1 might be a promising biomarker and therapeutic target in BC.

1 September 2014 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
NINaoko Ito
Naoko Ito
TITakeshi Iwaya
Takeshi Iwaya
KIKenichiro Ikeda
Kenichiro Ikeda
YKYusuke Kimura
Yusuke Kimura
YAYuji Akiyama
Yuji Akiyama
GWGo Wakabayashi
Go Wakabayashi

26 July 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Sekino YoheiSekino Yohei
Sekino Yohei
QPQuoc Thang Pham
Quoc Thang Pham
KKKohei Kobatake
Kohei Kobatake
HKHiroyuki Kitano
Hiroyuki Kitano
KIKenichiro Ikeda
Kenichiro Ikeda
JTJun Teishima
Jun Teishima
Homeobox genes function as master regulatory transcription factors during embryogenesis. HOXB5 is known to play an important role in several cancers. However, the biological role of HOXB5 in prostate cancer (PCa) is not fully elucidated. This study aimed to analyze the expression and function of HOXB5 and involvement of HOXB5 in neuroendocrine differentiation in PCa. Immunohistochemistry showed that 56 (43.8%) of 128 cases of localized PCa were positive for HOXB5. HOXB5-positive cases were associated with poor prostate-specific antigen recurrence-free survival after prostatectomy. Among 74 cases of metastatic PCa, 43 (58.1%) were positive for HOXB5. HOXB5 expression was higher in metastatic PCa than that in localized PCa. HOXB5 knockdown suppressed cell growth and invasion, but HOXB5 overexpression increased cell growth and invasion in PCa cell lines. Furthermore, HOXB5 regulated RET expression. Gene set enrichment analysis revealed that Nelson androgen response gene set was enriched in low HOXB5 expression group. RB1 knockout increased HOXB5 expression. Of note, additional p53 knockdown further increased HOXB5 expression in RB1 knockout cells. In silico analysis showed that HOXB5 expression was increased in neuroendocrine PCa (NEPC). These results suggest that HOXB5 may be a promising prognostic marker after prostatectomy and is involved in progression to NEPC.

30 November 2023 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
YKYuki Kohada
Yuki Kohada
KGKeisuke Goto
Keisuke Goto
RTRyo Tasaka
Ryo Tasaka
KNKensuke Nishida
Kensuke Nishida
KHKunihiro Hashimoto
Kunihiro Hashimoto
NHNobuyki Hinata
Nobuyki Hinata

5 July 2021 in International Journal of Urology
Verified
Journal Article
Closed access
PDF file
SMShunsuke Miyamoto
Shunsuke Miyamoto
KGKeisuke Goto
Keisuke Goto
YHYukiko Honda
Yukiko Honda
HTHiroaki Terada
Hiroaki Terada
SFShinsuke Fujii
Shinsuke Fujii
AMAkio Matsubara
Akio Matsubara